logo

For the Inventor, By the Inventor

Cary, NC, United States of America

Gordon R Julian

This inventor holds 7 USPTO granted patents. Top assignees: Demeter Biotechnologies, Ltd., Demegen, Inc.. Active years: 1996-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gordon R Julian. Retrieved from https://idiyas.com/inventor/gordon-r-julian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 180(Granted Patents)


Location History:

  • Bozeman, MT (US) (1998 - 1999)
  • Cary, NC (US) (1996 - 2001)

Company Filing History:

goldMedal4 out of 4 
 
Demeter Biotechnologies, Ltd.
 patents
silverMedal3 out of 9 
 
Demegen, Inc.
 patents

Years Active: 1996-2001

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6191110 - Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides (2001-02-20),
2. 6001805 - Method of enhancing wound healing by stimulating fibroblast and (1999-12-14),
3. 5968904 - Modified arginine containing lytic peptides and method of making the (1999-10-19),
4. 5773413 - Method of combating mammalian neoplasias, and lytic peptides therefor (1998-06-30),
5. 5744445 - Method of treating pulmonary disease states with non-naturally occuring (1998-04-28),
6. 5717064 - Methylated lysine-rich lytic peptides and method of making same by (1998-02-10),
7. 5561107 - Method of enhancing wound healing by stimulating fibroblast and (1996-10-01),

Title: Gordon R. Julian: Innovator in Wound Healing Technologies

Introduction

Gordon R. Julian is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of wound healing. With a total of 7 patents, he has developed innovative methods that enhance the healing process for mammalian subjects.

Latest Patents

Julian's latest patents include a groundbreaking method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides. This method involves treating wounds by administering a composition that contains a fibroblast and keratinocyte proliferatingly effective amount of an amphipathic peptide. The peptides are designed to be antimicrobially effective at the wound locus, promoting healing. Additionally, he has disclosed methods for stimulating the accelerated growth of dermal tissue in tissue cultures, which can be used to produce skin for grafting purposes.

Career Highlights

Throughout his career, Gordon R. Julian has worked with several companies, including Demeter Biotechnologies, Ltd. and Demegen, Inc. His work has significantly impacted the development of biotechnological solutions for wound treatment.

Collaborations

Julian has collaborated with various professionals in his field, including Jesse M. Jaynes, to further advance his research and innovations.

Conclusion

Gordon R. Julian's innovative approaches to wound healing through the use of amphipathic peptides demonstrate his commitment to improving medical treatments. His contributions continue to influence the field of biotechnology and wound care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…